Average Co-Inventor Count = 4.89
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (41 from 3,681 patents)
2. Icagen, Inc. (4 from 101 patents)
3. E. R. Squibb Sons, Inc. (3 from 1,624 patents)
44 patents:
1. 11008306 - Quinazolines as potassium ion channel inhibitors
2. 10676460 - Quinazolines as potassium ion channel inhibitors
3. 10214511 - Quinazolines as potassium ion channel inhibitors
4. 10173991 - Sulfone amide linked benzothiazole inhibitors of endothelial lipase
5. 9540323 - [object Object]
6. 9493412 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
7. 9458133 - Isoquinolines as potassium ion channel inhibitors
8. 9458164 - Pyrrolopyridazines as potassium ion channel inhibitors
9. 9458114 - Quinazolines as potassium ion channel inhibitors
10. 9403834 - Pyrrolotriazines as potassium ion channel inhibitors
11. 9242966 - Phthalazines as potassium ion channel inhibitors
12. 9169240 - Ketone linked benzothiazole inhibitors of endothelial lipase
13. 9120794 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
14. 9050345 - Pyrrolotriazines as potassium ion channel inhibitors
15. 8993557 - Pyridinedione carboxamide inhibitors of endothelial lipase